Prognostic factors for recurrent breast cancer: univariate and multivariate analyses including histologic grade and amplification of the c-erbB-2 proto-oncogene
- PMID: 1359174
Prognostic factors for recurrent breast cancer: univariate and multivariate analyses including histologic grade and amplification of the c-erbB-2 proto-oncogene
Abstract
Post-recurrence survival was examined in 62 breast cancer patients who had undergone curative radical mastectomies between 1974 and 1976 and suffered recurrences within 127 months of surgery. The prognostic value of 11 clinical, histological and genetic factors, including histologic grade of malignancy and amplification of oncogenes was analyzed using univariate and multivariate analyses. Not only the site of first recurrence, clinical stage and size of primary tumor at initial surgery, and disease-free period, but also histologic grade and amplification of the c-erbB-2 proto-oncogene were significant prognostic indicators of recurrent breast cancer. Multivariate analysis using Cox's regression model, histologic grade and amplification of c-erbB-2 in the primary tumor, as well as clinical stage at surgery and site of first recurrence, were shown to be major independent prognostic factors of recurrent breast cancer. Because post-recurrence prognosis was strongly influenced by the clinical, histological and genetic status of the primary breast cancer, appropriate evaluation of the primary tumor for the grade of aggressiveness of the cancer cells, as well as the extent of cancer spread, seem to be important.
Similar articles
-
Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer.Cancer Res. 1991 Jan 15;51(2):556-67. Cancer Res. 1991. PMID: 1670762
-
Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.BMC Cancer. 2007 Apr 12;7:63. doi: 10.1186/1471-2407-7-63. BMC Cancer. 2007. PMID: 17430582 Free PMC article.
-
Int-2/FGF3 amplification is a better independent predictor of relapse than c-myc and c-erbB-2/neu amplifications in primary human breast cancer.Mod Pathol. 1994 Dec;7(9):900-5. Mod Pathol. 1994. PMID: 7892157
-
Clinical and pathologic significance of the c-erbB-2 (HER-2/neu) oncogene.Pathol Annu. 1992;27 Pt 1:165-90. Pathol Annu. 1992. PMID: 1346551 Review.
-
[Current molecular prognostic factors in breast carcinoma].Schweiz Med Wochenschr. 1992 Oct 3;122(40):1471-8. Schweiz Med Wochenschr. 1992. PMID: 1357743 Review. German.
Cited by
-
p53 mutations and c-erbB-2 amplification in intraductal and invasive breast carcinomas of high histologic grade.Jpn J Cancer Res. 1993 Apr;84(4):394-401. doi: 10.1111/j.1349-7006.1993.tb00149.x. Jpn J Cancer Res. 1993. PMID: 8099903 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous